Juno Therapeutics, Inc. 4
4 · Juno Therapeutics, Inc. · Filed Mar 5, 2015
Insider Transaction Report
Form 4
Frohlich Mark W
See Remarks
Transactions
- Award
Stock Option (right to buy)
2015-03-03+50,500→ 50,500 totalExercise: $48.06Exp: 2025-03-02→ Common Stock (50,500 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option become vested and exercisable on April 3, 2015 and 1/48th of the shares subject to the option shall vest monthly thereafter.